Validation of an Automated Assay for Levetiracetam (Keppra) on Vitros 5600 | Zendy

Mahesheema Ali | Zendy; Estella Tam | Zendy; Stephen M. Roper | Zendy; Jing Cao | Zendy; Sridevi Devaraj | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Validation of an Automated Assay for Levetiracetam (Keppra) on Vitros 5600

Author(s) -

Mahesheema Ali,

Estella Tam,

Stephen M. Roper,

Jing Cao,

Sridevi Devaraj

Publication year - 2017

Publication title -

the journal of applied laboratory medicine

Language(s) - English

Resource type - Journals

eISSN - 2576-9456

pISSN - 2475-7241

DOI - 10.1373/jalm.2016.022186

Subject(s) - levetiracetam , medicine , coefficient of variation , immunoassay , therapeutic drug monitoring , pharmacology , drug , chromatography , chemistry , epilepsy , immunology , psychiatry , antibody

Levetiracetam (also known as Keppra™) is an antiepileptic drug that has been demonstrated as an effective adjunctive therapy in the treatment of partial onset of seizures, primary generalized tonic-clonic seizures, and myoclonic seizures. The aim of our study was to validate an automated quantitative immunoassay for levetiracetam at Texas Children's Hospital.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research